SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001479290-20-000013
Filing Date
2020-01-21
Accepted
2020-01-21 16:38:17
Documents
4
Effectiveness Date
2020-01-21

Document Format Files

Seq Description Document Type Size
1 S-8 s-8evergreen2020.htm S-8 124699
2 EXHIBIT 5.1 exhibit51opinionofcooleyllp.htm EX-5.1 9235
3 EXHIBIT 23.1 exhibit231pwcconsent.htm EX-23.1 3080
4 cooleya03.jpg GRAPHIC 4382
  Complete submission text file 0001479290-20-000013.txt   144130
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-235994 | Film No.: 20536752
SIC: 2834 Pharmaceutical Preparations